跳至主要内容
临床试验/NCT01133730
NCT01133730已完成不适用

The Analgesic Efficacy of the Transversalis Fascia Plane Block in Iliac Crest Bone Graft Harvesting

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2010年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
Opioid consumption

研究概览

简要总结

Hand or wrist surgery often requires the use of bony material in order to accomplish any associated reconstructive aspects required for the surgery. The iliac crest is often used as the source of bone for such surgery and harvesting from this site is performed simultaneously with the hand/wrist surgery. In terms of anesthesia, patients typically receive a supraclavicular nerve block for the hand/wrist surgery, and a general anesthestic for the bone graft, though spinal block may also be performed. This study will look at the use of a transversalis fascia plane (TFP) nerve block (ie, to numb the nerves going to the iliac crest) in combination with a general anesthetic to see if post-operative pain and opioid consumption is reduced using the TFP block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I-III
  • 18-85 years of age, inclusive
  • Weight 50kg+
  • Scheduled for elective upper limb surgery, which can be solely performed under a brachial plexus block, and requiring an ICBG

排除标准

  • Contraindications to regional blockade (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area)
  • History of alcohol or drug dependency/abuse
  • History of long term opioid intake or chronic pain disorder
  • History of significant psychiatric conditions that may affect patient assessment
  • Failure of upper extremity block
  • Previous iliac crest bone grafting
  • History of severe pelvic and hip conditions that could interfere with the long-term functional assessments of the study
  • Inability to understand the informed consent and demands of the study.

研究组 & 干预措施

Active treatment group

Experimental

Ultrasound-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine

干预措施: Active treatment (Drug)

Placebo arm

Placebo Comparator

Ultrasound-guided TFP block with 20ml of 5% dextrose solution

干预措施: Placebo Arm (Drug)

结局指标

主要结局

Opioid consumption

时间窗: 24 hours

Opioid consumption in the first 24 hours following ICBG. This will be expressed in terms of milligrams doses of IV morphine. Where other opioids are used, the doses will be converted to the equivalent IV morphine dose using standard opioid dosage conversion tables.

次要结局

  • Opioid consumption(7 days)
  • Complications(12 months)
  • Pain measures(48 hours)
  • Time of block performance(6 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验